Oppenheimer Reiterates Outperform on Transcat, Lowers Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Martin Yang has reiterated an Outperform rating for Transcat (NASDAQ:TRNS) but has lowered the price target from $155 to $130.
October 30, 2024 | 4:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oppenheimer has maintained an Outperform rating for Transcat but reduced the price target from $155 to $130, indicating a more cautious outlook.
The reiteration of an Outperform rating suggests continued confidence in Transcat's performance, but the lowered price target indicates a more cautious outlook, likely due to revised expectations or market conditions. This could lead to a short-term negative impact on the stock price as investors adjust to the new target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100